Satofuka H, Suzuki H, Tanaka T, Ubukata R, Hirose M, Yamamoto H
Biochem Biophys Rep. 2025; 41:101948.
PMID: 40028039
PMC: 11870228.
DOI: 10.1016/j.bbrep.2025.101948.
Leshem R, Sefton K, Wong C, Lin I, Isaac D, Niepel M
J Immunother Cancer. 2025; 13(1).
PMID: 39870492
PMC: 11772928.
DOI: 10.1136/jitc-2024-010683.
Lin K, Li P, Zhu X, Mao X, Peng J, Chen X
Front Immunol. 2024; 15:1431175.
PMID: 39669572
PMC: 11634862.
DOI: 10.3389/fimmu.2024.1431175.
Trautmann T, Yakobian N, Nguyen R
Cancer Metastasis Rev. 2024; 43(4):1445-1461.
PMID: 39317919
PMC: 11554711.
DOI: 10.1007/s10555-024-10214-6.
Van der Vreken A, Vanderkerken K, de Bruyne E, de Veirman K, Breckpot K, Menu E
Exp Hematol Oncol. 2024; 13(1):66.
PMID: 38987856
PMC: 11238373.
DOI: 10.1186/s40164-024-00535-1.
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Krakow E, Brault M, Summers C, Cunningham T, Biernacki M, Black R
Blood. 2024; 144(10):1069-1082.
PMID: 38683966
PMC: 11406181.
DOI: 10.1182/blood.2024024105.
Single-cell multi-ome regression models identify functional and disease-associated enhancers and enable chromatin potential analysis.
Mitra S, Malik R, Wong W, Rahman A, Hartemink A, Pritykin Y
Nat Genet. 2024; 56(4):627-636.
PMID: 38514783
PMC: 11018525.
DOI: 10.1038/s41588-024-01689-8.
Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity.
Orozco R, Marquardt K, Pratumchai I, Shaikh A, Mowen K, Domissy A
PLoS Pathog. 2024; 20(3):e1012095.
PMID: 38512979
PMC: 10987006.
DOI: 10.1371/journal.ppat.1012095.
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Lin C, Levy P, Alflen A, Apriamashvili G, Ligtenberg M, Vredevoogd D
Cancer Cell. 2024; 42(4):623-645.e10.
PMID: 38490212
PMC: 11003465.
DOI: 10.1016/j.ccell.2024.02.016.
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn.
Albelda S
Nat Rev Clin Oncol. 2023; 21(1):47-66.
PMID: 37904019
DOI: 10.1038/s41571-023-00832-4.
Single-cell transcriptomics delineates the immune cell landscape in equine lower airways and reveals upregulation of FKBP5 in horses with asthma.
Riihimaki M, Fegraeus K, Nordlund J, Waern I, Wernersson S, Akula S
Sci Rep. 2023; 13(1):16261.
PMID: 37758813
PMC: 10533524.
DOI: 10.1038/s41598-023-43368-4.
CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with .
Diupotex M, Zamora-Chimal J, Gajon J, Bonifaz L, Becker I
Front Immunol. 2023; 14:1231836.
PMID: 37691941
PMC: 10485697.
DOI: 10.3389/fimmu.2023.1231836.
Barriers to overcoming immunotherapy resistance in glioblastoma.
Gillette J, Wang E, Dowd R, Toms S
Front Med (Lausanne). 2023; 10:1175507.
PMID: 37275361
PMC: 10232794.
DOI: 10.3389/fmed.2023.1175507.
The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases.
Choi H, Kim Y, Jung Y
Immune Netw. 2023; 23(1):e10.
PMID: 36911798
PMC: 9995995.
DOI: 10.4110/in.2023.23.e10.
Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.
Wan S, Zhao E, Weissinger D, Krantz B, Werba G, Freeman D
Front Immunol. 2023; 14:1067352.
PMID: 36798126
PMC: 9927010.
DOI: 10.3389/fimmu.2023.1067352.
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis.
Qin L, Cui Y, Yuan T, Chen D, Zhao R, Li S
Nat Commun. 2022; 13(1):6051.
PMID: 36229619
PMC: 9561169.
DOI: 10.1038/s41467-022-33793-w.
Transcriptomic Profiling Identifies CD8 T Cells in the Brain of Aged and Alzheimer's Disease Transgenic Mice as Tissue-Resident Memory T Cells.
Altendorfer B, Unger M, Poupardin R, Hoog A, Asslaber D, Gratz I
J Immunol. 2022; 209(7):1272-1285.
PMID: 36165202
PMC: 9515311.
DOI: 10.4049/jimmunol.2100737.
The Memory T Cell "Communication Web" in Context with Gastrointestinal Disorders-How Memory T Cells Affect Their Surroundings and How They Are Influenced by It.
Knauss A, Gabel M, Neurath M, Weigmann B
Cells. 2022; 11(18).
PMID: 36139354
PMC: 9497182.
DOI: 10.3390/cells11182780.
Development of a human antibody that exhibits antagonistic activity toward CC chemokine receptor 7.
Jang M, Ismail N, Yu Y
Antib Ther. 2022; 5(3):192-201.
PMID: 35967907
PMC: 9372883.
DOI: 10.1093/abt/tbac016.
CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma.
Zhou W, Wang Y, Yan C, Du W, Al-Aroomi M, Zheng L
Discov Oncol. 2022; 13(1):67.
PMID: 35904690
PMC: 9338204.
DOI: 10.1007/s12672-022-00533-x.